|
CCDC122 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.964200E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.141200E-01 |
| Normal-vs-Stage2 |
5.913200E-01 |
| Normal-vs-Stage3 |
2.779100E-04 |
| Normal-vs-Stage4 |
1.764820E-04 |
| Stage1-vs-Stage2 |
7.313800E-01 |
| Stage1-vs-Stage3 |
4.783900E-04 |
| Stage1-vs-Stage4 |
1.613630E-04 |
| Stage2-vs-Stage3 |
5.316000E-02 |
| Stage2-vs-Stage4 |
4.318500E-02 |
| Stage3-vs-Stage4 |
9.171800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.097700E-02 |
| Normal-vs-AfricanAmerican |
7.881600E-03 |
| Normal-vs-Asian |
5.080000E-01 |
| Caucasian-vs-AfricanAmerican |
3.355600E-01 |
| Caucasian-vs-Asian |
1.048810E-01 |
| AfricanAmerican-vs-Asian |
2.833900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.124500E-02 |
| Normal-vs-Female |
1.321740E-02 |
| Male-vs-Female |
7.631400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.240400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.036400E-02 |
| Normal-vs-Age(61-80Yrs) |
8.256500E-03 |
| Normal-vs-Age(81-100Yrs) |
1.126300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.794800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.044200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.603600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.466600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.572590E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.949560E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.650400E-01 |
| Normal-vs-Grade 2 |
5.895600E-01 |
| Normal-vs-Grade 3 |
1.301060E-03 |
| Normal-vs-Grade 4 |
4.22720000003984E-07 |
| Grade 1-vs-Grade 2 |
7.582600E-01 |
| Grade 1-vs-Grade 3 |
4.299600E-02 |
| Grade 1-vs-Grade 4 |
2.235200E-04 |
| Grade 2-vs-Grade 3 |
1.008420E-04 |
| Grade 2-vs-Grade 4 |
9.21919984797626E-10 |
| Grade 3-vs-Grade 4 |
3.960900E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.684800E-01 |
| Normal-vs-ccB subtype |
1.167110E-04 |
| ccA subtype-vs-ccB subtype |
3.90159999863471E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.120200E-02 |
| Normal-vs-N1 |
3.483800E-02 |
| N0-vs-N1 |
3.222000E-01 |
|
|
